Suppressing endothelial senescence: A comprehensive analysis of metformin's mechanisms and implications
Life Sciences · 2025
DOI: 10.1016/j.lfs.2025.123730 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life Sciences, 2025. Verfasst von Dongsheng Shang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China. Hauptthemen laut MEDLINE: Metformin, Cellular Senescence, Cardiovascular Diseases, Hypoglycemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 95 Literaturangaben. Gefördert von: Senior Talent Foundation of Jiangsu University, Jiangsu University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Endothelial cell senescence serves as a pivotal driver of vascular dysfunction and cardiovascular pathogenesis. Metformin, a first-line antidiabetic agent, has expanded beyond its traditional role in glycemic control, with accumulating evidence underscoring its anti-aging properties. Endothelial dysfunction constitutes a central pathological basis for the development and progression of cardiovascular disease (CVD), and the restoration of endothelial function has been demonstrated to significantly mitigate cardiovascular event risks. Preclinical and clinical studies indicate that metformin-whether administered as monotherapy or in combination regimens-has demonstrated significant potential in the treatment of CVD by ameliorating endothelial dysfunction. Emerging evidence indicates metformin attenuates endothelial senescence and enhances cellular function via pleiotropic mechanisms, thereby preserving endothelial function and retarding cardiovascular disease (CVD) progression. This review systematically elucidates current understanding of metformin's senescence-inhibitory mechanisms in endothelial cells and evaluates its translational potential for CVD intervention, which may provide novel strategies for next-generation CVD pharmacotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China.
- Jiangsu University Staff Hospital, Jiangsu University, Zhenjiang, Jiangsu 212013, China.
- School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, China. Electronic address: hanqing@ujs.edu.cn.
- School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China. Electronic address: zhigangtu@ujs.edu.cn.
Förderung
- Senior Talent Foundation of Jiangsu University
- Jiangsu University
- National Natural Science Foundation of China
Zitieren
APA
Shang, D., Zhang, X., Liu, H., & Tu, Z. (2025). Suppressing endothelial senescence: A comprehensive analysis of metformin's mechanisms and implications. Life Sciences. https://doi.org/10.1016/j.lfs.2025.123730
Vancouver
Shang D, Zhang X, Liu H, Tu Z. Suppressing endothelial senescence: A comprehensive analysis of metformin's mechanisms and implications. Life Sciences. 2025. doi:10.1016/j.lfs.2025.123730
BibTeX
@article{Shang2025,
author = {Shang, Dongsheng and Zhang, Xueli and Liu, Hanqing and Tu, Zhigang},
title = {Suppressing endothelial senescence: A comprehensive analysis of metformin's mechanisms and implications},
journal = {Life Sciences},
year = {2025},
doi = {10.1016/j.lfs.2025.123730}
}
EUVIMED